Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsDENTALGeneric

EXTRA-STRENGTH AIM

SODIUM MONOFLUOROPHOSPHATE

Standard Dose
1.2%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview EXTRA-STRENGTH AIM is listed in Drugs@FDA under application 019518 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM MONOFLUOROPHOSPHATE Form and strength PASTE;DENTAL - 1.2% Sponsor CHESEBROUGH PONDS Submission history Latest submission status date: 1992-03-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview EXTRA-STRENGTH AIM is listed in Drugs@FDA under application 019518 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM MONOFLUOROPHOSPHATE Form and strength PASTE;DENTAL - 1.2% Sponsor CHESEBROUGH PONDS Submission history Latest submission status date: 1992-03-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.